4
Changes in Ownership
Inhibikase Therapeutics, Inc. Filed Acc 0000950170-25-026652
Options or other derivatives
- President & Head of R&D acquired 1,100,705 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Cabell Christopher · President & Head of R&D
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-02-21 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +1,100,705 | 1,100,705 | D |
Loading xslF345X05/ownership.xml…